Curi Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-159
Closed -$5K 221
2022
Q2
$5K Hold
159
﹤0.01% 444
2022
Q1
$7K Hold
159
﹤0.01% 385
2021
Q4
$9K Buy
+159
New +$11K ﹤0.01% 325
2021
Q1
Sell
-98
Closed -$9K 121
2020
Q4
$9K Buy
+98
New +$7.81K 0.01% 258

Other funds holding ARKG

Curi Wealth Management's ARKG Position: Q3 2022 in Review

Curi Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 159 shares — an estimated $5K sold.

Curi Wealth Management first reported a position in ARKG in Q4 2020 and held it in 4 quarters. The position peaked at $9K in Q4 2021. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

  • Curi Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
  • Curi Wealth Management sold 159 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $5K.
  • Curi Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 4 quarters.
  • Curi Wealth Management's ARK Genomic Revolution ETF position peaked at $9K in Q4 2021.
  • 311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on Curi Wealth Management's 13F filing for Q3 2022, filed 8 Nov 2022.